NIH-funded research U01 cooperative agreement

Peptidome-based tools for faster, precise detection of nontuberculous mycobacteria

Official title: Peptidome-Driven Algorithms for Faster and More Precise Mycobacterial Detection

Funded at Tulane University of Louisiana · NIH-11413783 · Data updated 2026-11-12

A new test uses peptide patterns and mass spectrometry to quickly and accurately identify NTM bacteria and predict which drugs will work best for people with chronic lung disease.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 10, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$535,257
NIH project number5U01AI185864-02
Project IDNIH-11413783 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with chronic lung disease suspected of harboring NTM infections would be most suitable.

Less likely to help

Patients without NTM infection or not undergoing diagnostic evaluation for NTM are unlikely to benefit.

What this research studies

If you have chronic lung disease, this project aims to improve how we identify NTM infections and choose effective antibiotics using a peptide-based MS assay called MycoID. The researchers will refine and test the LC-MS/MS workflow to distinguish NTM species and subspecies and to forecast drug susceptibility, which could shorten time to correct treatment. This work builds on prior findings showing peptide variants can serve as reliable biomarkers for mycobacterial identification. The study will evaluate accuracy, reliability, and practicality of applying this approach in clinical diagnostics. By moving toward a rapid, precise test, patients could avoid ineffective therapies and reduce drug-related toxicity.

Why it matters

Potential benefit: If successful, patients with NTM infections could receive faster and more accurate treatment.

How similar studies have gone: Previous work suggests MS-based peptide biomarkers can accurately identify mycobacterial species, supporting potential clinical benefit.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Fan, Jia — Tulane University of Louisiana
  • Study coordinator: Fan, Jia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.